Cellular and subcellular context determine outputs from signaling biosensors

Methods in Cell Biology

Volumn 132, Issue , 2016, Pages 319-337

  Devost, Dominic ^a   Audet, Nicolas ^a   Zhou, Cynthia ^a   Kobayashi, Hiroyuki ^b   Bonin, Hélène ^b   Lukashova, Viktorya ^b   Gouill, Christian Le ^b   Bouvier, Michel ^b   Hébert, Terence E ^a  

^a MCGILL UNIVERSITY   (Canada)

^b INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE;

CELL NUCLEUS; ENZYME ACTIVATION; ENZYMOLOGY; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENETIC PROCEDURES; HEK293 CELL LINE; HELA CELL LINE; HUMAN; METABOLISM; SIGNAL TRANSDUCTION;

BIOSENSING TECHNIQUES; CELL NUCLEUS; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLUORESCENCE RESONANCE ENERGY TRANSFER; HEK293 CELLS; HELA CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE;

EID: 84962068587     PISSN: 0091679X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.mcb.2015.11.010     Document Type: Article

References (20)

1. Busino, L., Chiesa, M., Draetta, G. F., & Donzeli, M. (2004). Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysis. Oncogene, 23, 2050-2056.
2. Chang, L., & Karin, M. (2001). Mammalian MAP kinase signalling cascades. Nature, 410, 37-40.
3. Davidson, M. M., Nesti, C., Panlenzuela, L., Walker, W. F., Hernandez, E., Protas, L., et al. (2005). Novel cell lines derived from adult human ventricular cardiomyocytes. Journal of Molecular and Cellular Cardiology, 39, 133-147.
4. Deng, H., Sun, H., & Fang, Y. (2013). Label-free cell phenotypic assessment of the biased agonism and efficacy of agonists at the endogenous muscarinic M3 receptors. Journal of Pharmacological and Toxicological Methods, 68, 323-333.
5. Dimitri, C. A., Dowdle, W., MacKeigan, J. P., Blenis, J., & Murphy, L. O. (2005). Spatially separate docking sites on ERK2 regulate distinct signaling events in vivo. Current Biology, 15, 1319-1324.
6. Domazet, I., Holleran, B. J., Richard, A., Vandenberghe, C., Lavigne, P., Escher, E., et al. (2015). Characterization of angiotensin II molecular determinants involved in AT1 receptor functional selectivity. Molecular Pharmacology, 87, 982-995.
7. Galés, C., Rebois, R. V., Hogue,M., Trieu, P., Breit, A., Hébert, T. E., et al. (2005). Real-time monitoring of receptor and G-protein interactions in living cells. Nature Methods, 2, 177-184.
8. Harvey, C. D., Ehrhardt, A. G., Cellurale, C., Zhong, H., Yasuda, R., Davis, R. J., et al. (2008). A genetically encoded fluorescent sensor of ERK activity. Proceedings of the National Academy of Sciences of the United States of America, 105, 19264-19269.
9. Kenakin, T., & Christopoulos, A. (2013a). Measurements of ligand bias and functional affinity. Nature Reviews Drug Discovery, 12, 483.
10. Kenakin, T., & Christopoulos, A. (2013b). Signalling bias in new drug discovery: detection, quantification and therapeutic impact. Nature Reviews Drug Discovery, 12, 205-216.
11. 1 as a modulator of M3 muscarinic receptor signalling and a novel roles of Gb1 subunits in the modulation of cellular signalling. Cellular Signalling, 27, 1597-1608.
12. Kim, E. K., & Choi, E. J. (2010). Pathological roles of MAPK signaling pathways in human diseases. Biochimica et Biophysica Acta, 1802, 396-405.
13. Leduc, M., Breton, B., Galés, C., Le Gouill, C., Bouvier, M., Chemtob, S., et al. (2009). Functional selectivity of natural and synthetic prostaglandin EP4 receptor ligands. Journal of Pharmacology and Experimental Therapeutics, 331, 297-307.
14. Luttrell, L. M. (2014). Minireview: more than just a hammer: ligand "bias" and pharmaceutical discovery. Molecular Endocrinology, 28, 281-294.
15. Namkung, Y., Radresa, O., Armando, S., Devost, D., Beautrait, A., Le Gouill, C., et al. (2015). Quantifying biased signaling in GPCRs using BRET-based biosensors. Methods. in press.
16. Sauliere, A., Bellot, M., Paris, H., Denis, C., Finana, F., et al. (2012). Deciphering biasedagonism complexity reveals a new active AT(1) receptor entity. Nature Chemical Biology, 8, 622-630.
17. Sudol, M., & Hunter, T. (2000). New wrinkles for an old domain. Cell, 103, 1001-1004. Thomas, G. M., & Huganir, R. L. (2004). MAPK cascade signalling and synaptic plasticity. Nature Reviews Neuroscience, 5, 173-183.
18. Thomas, G. M., & Huganir, R. L. (2004). MAPK cascade signalling and synaptic plasticity. Nature Reviews Neuroscience, 5, 173-183
19. Tohgo, A., Pierce, K. L., Choy, E.W., Lefkowitz, R. J., & Luttrell, L. M. (2002). b-arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation. Journal of Biological Chemistry, 277, 9429-9436.
20. Wei, H., Ahn, S., Shenoy, S. K., Karnik, S. S., Hunyady, L., & Luttrell, L. M. (2003). Independent b-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proceedings of the National Academy of Sciences of the United States of America, 100, 10782.